Xcout IntelMilestone Pharmaceuticals
Milestone Pharmaceuticals Inc. is a biopharmaceutical company based in Montréal, Canada, specializing in the creation and commercialization of cardiovascular therapeutics. Their flagship product, etripamil, an innovative channel blocker, is currently in advanced clinical development. It is undergoing Phase III trials for the treatment of paroxysmal supraventricular tachycardia (PSVT) in the United States and Canada, while also progressing through Phase II trials for atrial fibrillation and rapid ventricular rate. Furthermore, Milestone Pharmaceuticals has forged a licensing and collaboration alliance with Ji Xing Pharmaceuticals to advance and distribute etripamil for both preventative and therapeutic applications in humans. The company was founded in 2003.
Subscribe to see Milestone Pharmaceuticals’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Milestone Pharmaceuticals at a glance
Milestone Pharmaceuticals is a pharmaceuticals company headquartered in Montreal, Canada. It is publicly listed (MIST) with a market capitalisation of $94.3M. Xcout tracks 27 named people at Milestone Pharmaceuticals, including Joseph G. Oliveto (Chief Executive Officer, President & Director).
Milestone Pharmaceuticals leadership
- Joseph G. OlivetoChief Executive Officer, President & Director
- Joseph OlivetoPresident & CEO
- Jeff NelsonChief Operating Officer
- Amit HasijaChief Financial Officer & Executive Vice President of Corporate Development
- David Bharucha FACCChief Medical Officer
- David B. BharuchaChief Medical Officer
21 more named people on record for Milestone Pharmaceuticals, with roles, board committees and tenure — see the full roster →
Milestone Pharmaceuticals funding rounds before its IPO
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $13M | — |
Financing after the IPO — public offerings and SEC Form D private placements — is not listed as a funding round.
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Get Milestone Pharmaceuticals's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Milestone Pharmaceuticals in Xcout Intel
- 27 named people with titles, LinkedIn and board committees
- 1 funding round before the IPO with the investors in each, and who they co-invest with
- 2 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access